Inflamyar

Manufacturer: Pekana-Naturheilmittel GmbH
Effective date: 2022-12-15
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 02:18:53

Label at a glance#

ProductInflamyar

Active ingredientARNICA MONTANA WHOLE, BELLIS PERENNIS WHOLE, BRYONIA DIOICA ROOT, GUAIACUM OFFICINALE RESIN, RHODODENDRON TOMENTOSUM LEAFY TWIG, RUTA GRAVEOLENS WHOLE, TOXICODENDRON PUBESCENS LEAF, VISCUM ALBUM FRUIT

Label structure8 sections

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

for sports injuries and joint pain

Ingredients

OTC - ACTIVE INGREDIENT SECTION

Arnica montana	4X
Bellis perennis	4X
Bryonia cretica	4X
Guajacum	6X
Ledum palustre	12X
Ruta graveolens	4X
Toxicodendron quercifolium	8X
Viscum album	4X

INACTIVE INGREDIENT SECTION

Selected ingredients prepared by spagyric processes. Contains sucrose.

Indications

INDICATIONS & USAGE SECTION

For relief of minor sports injuries, including muscle strains, joint pain, sprains, and bruises. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.

Dosage

DOSAGE & ADMINISTRATION SECTION

Unless otherwise prescribed, adults take 10 pellets, 4 times per day. For pediatric dosages, consult your practitioner.

Warning

WARNINGS SECTION

If symptoms persist, contact a licensed practitioner. If you have known sensitivity to any of the ingredients, please consult your licensed practitioner before use. If you are pregnant or nursing a baby, seek the advice of a health care professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.

STORAGE AND HANDLING SECTION

Protect from light and heat.

Tamper Evident

SPL UNCLASSIFIED SECTION

Do not use this product if tamper evident strip is broken or removed from base of cap.

SPL UNCLASSIFIED SECTION

To report adverse events, contact BioResource at 321B Blodgett Street, Cotati, CA 94931

Manufactured by:
PEKANA® GmbH
D-88353 Kisslegg

Distributed by:
BioResource Inc.
Cotati, CA 94931
Made in Germany

PRINCIPAL DISPLAY PANEL - 10 g Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

INFLAMYAR™

Oral Pellets

Homeopathic
Medicine

For relief of minor
sports injuries, including
muscle strains,
joint pain, sprains,
and bruises

Application of this ho-
meopathic remedy for
the designated usage is
exclusively based on ho-
meopathic experience.
With severe forms of this
disease, a clinically pro-
ven therapy is indicated.

480 Pellets
(10 g)

PEKANA^®

PRINCIPAL DISPLAY PANEL - 10 g Bottle Carton

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59469-172-10	Inflamyar	480 in 1 BOTTLE	PELLET	480		4
59469-172-10	Inflamyar	1 in 1 CARTON	PELLET	1		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59469-172	INFLAMYAR (ARNICA MONTANA, BELLIS PERENNIS, BRYONIA CRETICA SUBSP. DIOICA ROOT, GUAIACUM OFFICINALE RESIN, LEDUM PALUSTRE TWIG, RUTA GRAVEOLENS WHOLE, TOXICODENDRON PUBESCENS LEAF, AND VISCUM ALBUM FRUIT) PELLET [PEKANA-NATURHEILMITTEL GMBH]	4	Current NDC, Legacy NDC, 2 package rows	20221217_74d1533e-3a39-465b-93b9-08c97b8a4776.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ARNICA MONTANA	ACTIVE INGREDIENT	O80TY208ZW	1
BELLIS PERENNIS	ACTIVE INGREDIENT	2HU33I03UY	1
BRYONIA CRETICA SUBSP. DIOICA ROOT	ACTIVE INGREDIENT	53UB5FH7CX	1
GUAIACUM OFFICINALE RESIN	ACTIVE INGREDIENT	N0K2Z502R6	1
LEDUM PALUSTRE TWIG	ACTIVE INGREDIENT	877L01IZ0P	1
RUTA GRAVEOLENS WHOLE	ACTIVE INGREDIENT	181JI0338P	1
TOXICODENDRON PUBESCENS LEAF	ACTIVE INGREDIENT	6IO182RP7A	1
VISCUM ALBUM FRUIT	ACTIVE INGREDIENT	P83EQ521R3	1
ARNICA MONTANA	ACTIVE MOIETY	O80TY208ZW	1
BELLIS PERENNIS	ACTIVE MOIETY	2HU33I03UY	1
BRYONIA CRETICA SUBSP. DIOICA ROOT	ACTIVE MOIETY	53UB5FH7CX	1
GUAIACUM OFFICINALE RESIN	ACTIVE MOIETY	N0K2Z502R6	1
LEDUM PALUSTRE TWIG	ACTIVE MOIETY	877L01IZ0P	1
RUTA GRAVEOLENS WHOLE	ACTIVE MOIETY	181JI0338P	1
TOXICODENDRON PUBESCENS LEAF	ACTIVE MOIETY	6IO182RP7A	1
VISCUM ALBUM FRUIT	ACTIVE MOIETY	P83EQ521R3	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Inflamyar
ARNICA MONTANA, BELLIS PERENNIS, BRYONIA CRETICA SUBSP. DIOICA ROOT, GUAIACUM OFFICINALE RESIN, LEDUM PALUSTRE TWIG, RUTA GRAVEOLENS WHOLE, TOXICODENDRON PUBESCENS LEAF, and VISCUM ALBUM FRUIT
ARNICA MONTANA WHOLE
BELLIS PERENNIS WHOLE
BRYONIA DIOICA ROOT
GUAIACUM OFFICINALE RESIN
RHODODENDRON TOMENTOSUM LEAFY TWIG
RUTA GRAVEOLENS WHOLE
TOXICODENDRON PUBESCENS LEAF
VISCUM ALBUM FRUIT
SUCROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
59469-172	59469-172-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ARNICA MONTANA WHOLE	O80TY208ZW	ACTIB
BELLIS PERENNIS WHOLE	2HU33I03UY	ACTIB
BRYONIA DIOICA ROOT	53UB5FH7CX	ACTIB
GUAIACUM OFFICINALE RESIN	N0K2Z502R6	ACTIB
RHODODENDRON TOMENTOSUM LEAFY TWIG	877L01IZ0P	ACTIB
RUTA GRAVEOLENS WHOLE	181JI0338P	ACTIB
TOXICODENDRON PUBESCENS LEAF	6IO182RP7A	ACTIB
VISCUM ALBUM FRUIT	P83EQ521R3	ACTIB
SUCROSE	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 62 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Inflamyar	ARNICA MONTANA, BELLIS PERENNIS, BRYONIA CRETICA SUBSP. DIOICA ROOT, GUAIACUM OFFICINALE RESIN, LEDUM PALUSTRE TWIG, RUTA GRAVEOLENS WHOLE, TOXICODENDRON PUBESCENS LEAF, AND VISCUM ALBUM FRUIT	Pekana-Naturheilmittel GmbH	74d1533e-3a39-465b-93b9-08c97b8a4776	2022-12-15	Warnings	Exact identifier ndc (package): 59469-172-10 ndc (product): 59469-172 ndc11 (package): 59469017210 spl id: 881b458b-9908-4f15-b509-20febb2c291e spl set id: 74d1533e-3a39-465b-93b9-08c97b8a4776

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.